Zelluna Comes To Rescue Of Ultimovacs As Cancer Vaccine Is Jettisoned

Faced with going out of business after repeated Phase II fails in a variety of tumor types for its investigational universal cancer vaccine, Norway’s Ultimovacs has been saved by compatriot Zelluna.